People: Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)
600267.SS on Shanghai Stock Exchange
14.24CNY
2:59am EDT
14.24CNY
2:59am EDT
Price Change (% chg)
¥-0.41 (-2.80%)
¥-0.41 (-2.80%)
Prev Close
¥14.68
¥14.68
Open
¥14.58
¥14.58
Day's High
¥14.76
¥14.76
Day's Low
¥14.18
¥14.18
Volume
4,437,784
4,437,784
Avg. Vol
10,476,495
10,476,495
52-wk High
¥17.95
¥17.95
52-wk Low
¥13.14
¥13.14
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Hua Bai |
66 | 2009 | Chairman of the Board, President |
Guoqing Lou |
49 | 2009 | Vice Chairman of the Board |
Lingli Wei |
39 | 2011 | Chief Financial Officer |
Rusheng Bao |
42 | 2013 | Senior Vice President, Director |
Jianqiu Lin |
46 | 2013 | Senior Vice President, Director |
Haibin Wang |
43 | 2013 | Senior Vice President, Director |
Wende Chen |
50 | 2013 | Senior Vice President |
Shihong Cai |
52 | 2009 | Vice President, Director |
Rui Di |
57 | 2009 | Vice President |
Qiandao Gu |
42 | 2009 | Vice President |
Ling Jiang |
42 | 2011 | Vice President |
Burman Kumar |
62 | 2009 | Vice President |
Di Lin |
56 | 2009 | Vice President |
Jiali Luo |
51 | 2009 | Vice President |
Zhengli Tao |
58 | 2009 | Vice President |
Weibing Wang |
45 | 2009 | Vice President |
Shunbing Yu |
50 | 2009 | Vice President |
Tianmin Zhu |
53 | 2010 | Vice President |
Wei Zhang |
49 | 2001 | Secretary of the Board |
Jianhua Wu |
55 | 2010 | Director |
Yunpei Guo |
65 | 2013 | Independent Director |
Chao Lu |
44 | 2013 | Independent Director |
Cheng Zhang |
58 | 2013 | Independent Director |
Biographies
| Name | Description |
|---|---|
Hua Bai |
Mr. Bai Hua has been serving as Chairman of the Board and President in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 9, 2009. He also serves as Chairman of the Board, Executive Director, General Manager and Director in other 12 companies. |
Guoqing Lou |
Mr. Lou Guoqing has been serving as Vice Chairman of the Board in Zhejiang Hisun Pharmaceutical Co., Ltd. since April 21, 2009. He also serves as Vice Chairman of the Board, Deputy General Manager and Director in other three companies. He used to be Deputy General Manager and Director of a Zhejiang-based silk company. |
Lingli Wei |
Ms. Wei Lingli has been serving as Chief Financial Officer in Zhejiang Hisun Pharmaceutical Co., Ltd. since Febuary 2011. She also serves as Director in another company. |
Rusheng Bao |
Mr. Bao Rusheng has been serving as Senior Vice President and Director in Zhejiang Hisun Pharmaceutical Co., Ltd. since April 24, 2013. He also serves as Chairman of the Board and Director in other three companies. He served as Assistant General Manager in the Company. |
Jianqiu Lin |
Mr. Lin Jianqiu has been serving as Senior Vice President and Director in Zhejiang Hisun Pharmaceutical Co., Ltd. since April 24, 2013. He used to be Deputy General Manager and Assistant General Manager in the Company. He also served as Executive Director and Deputy General Manager in a Hangzhou-based company. |
Haibin Wang |
|
Wende Chen |
Mr. Chen Wende has been serving as Senior Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since April 24, 2013. He also serves as General Manager and Executive Director in a Shanghai-based technology company. He served as Senior Vice President in AstraZeneca China, as well as Chief Operating Officer in a pharmaceutical group. |
Shihong Cai |
Mr. Cai Shihong has been serving as Vice President and Director in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 9, 2009. He also serves as Chairman of the Board and Director in other two companies. He served as Chief Financial Officer and Deputy General Manager in the Company. |
Rui Di |
Ms. Di Rui has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 09, 2009. She used to serve as Deputy General Manager of the Company, Director in Environment Safety Resources Pte Ltd. |
Qiandao Gu |
Mr. Gu Qiandao has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 09, 2009. He used to be Assistant General Manager of the Company. |
Ling Jiang |
Mr. Jiang Ling has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since February 2011. He also serves as Director in other three Zhejiang-based companies. He used to serve as Deputy General Manager, Chief Financial Officer, Assistant General Manager and Head of General Office in the Company. He is a Certified Public Accountant. |
Burman Kumar |
Mr. Burman Subrata Kumar has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 9, 2009. He used to be Deputy General Manager of the Company. |
Di Lin |
Mr. Lin Di has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 9, 2009. He used to be Deputy General Manager in the Company. |
Jiali Luo |
Mr. Luo Jiali has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 9, 2009. He used to serve as Deputy General Manager in the Company. |
Zhengli Tao |
Mr. Tao Zhengli has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 9, 2009. He used to serve as Deputy General Manager of the Company, Chief Engineer in Zhejiang Medicine Co., Ltd., and Deputy Head of a Xinchang-based pharmaceutical plant. |
Weibing Wang |
Mr. Wang Weibing has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 9, 2009. He used to be Deputy General Manager in the Company. |
Shunbing Yu |
Mr. Yu Shunbing has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since January 9, 2009. He used to be Assistant General Manager and Deputy General Manager in the Company. |
Tianmin Zhu |
Mr. Zhu Tianmin has been serving as Vice President in Zhejiang Hisun Pharmaceutical Co., Ltd. since August 3, 2010. He used to be Senior Director in two United States-based companies. |
Wei Zhang |
|
Jianhua Wu |
Ms. Wu Jianhua has been serving as Director in Zhejiang Hisun Pharmaceutical Co., Ltd. since April 19, 2010. She also serves as Vice Chairman of the Board and Staff Elected Director in other two Zhejiang-based companies. She used to be Vice Chairman of the Board and General Manager in Zhejiang Orient Holdings Co., Ltd. |
Yunpei Guo |
Mr. Guo Yunpei has been serving as Independent Director in Zhejiang Hisun Pharmaceutical Co., Ltd. since April 24, 2013. He served as Executive President in a Beijing-based group. |
Chao Lu |
Mr. Lu Chao has been serving as Independent Director in Zhejiang Hisun Pharmaceutical Co., Ltd. since April 24, 2013. He holds a Ph.D. in Management from Renmin University of China. |
Cheng Zhang |
Mr. Zhang Cheng has been serving as Independent Director in Zhejiang Hisun Pharmaceutical Co., Ltd. since April 24, 2013. He also serves as Independent Director in China Fortune Land Development Co., Ltd., ZHEJIANG BUSEN GARMENTS CO., LTD., Zhejiang Vie Science and Technology Co., Ltd. and Zhejiang Kaier New Materials Co., Ltd. He holds a Master's degree in Law from Southwest University of Political Science and Law, China. He is a Professor of Tsinghua University, China. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Hua Bai |
1,749,000 |
Guoqing Lou |
-- |
Lingli Wei |
257,000 |
Rusheng Bao |
463,000 |
Jianqiu Lin |
439,000 |
Haibin Wang |
393,000 |
Wende Chen |
430,000 |
Shihong Cai |
646,300 |
Rui Di |
794,000 |
Qiandao Gu |
409,000 |
Ling Jiang |
412,000 |
Burman Kumar |
548,000 |
Di Lin |
601,000 |
Jiali Luo |
908,000 |
Zhengli Tao |
535,000 |
Weibing Wang |
673,000 |
Shunbing Yu |
404,000 |
Tianmin Zhu |
1,020,000 |
Wei Zhang |
322,000 |
Jianhua Wu |
-- |
Yunpei Guo |
-- |
Chao Lu |
-- |
Cheng Zhang |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Hua Bai |
0 | 0 |
Guoqing Lou |
0 | 0 |
Lingli Wei |
0 | 0 |
Rusheng Bao |
0 | 0 |
Jianqiu Lin |
0 | 0 |
Haibin Wang |
0 | 0 |
Wende Chen |
0 | 0 |
Shihong Cai |
0 | 0 |
Rui Di |
0 | 0 |
Qiandao Gu |
0 | 0 |
Ling Jiang |
0 | 0 |
Burman Kumar |
0 | 0 |
Di Lin |
0 | 0 |
Jiali Luo |
0 | 0 |
Zhengli Tao |
0 | 0 |
Weibing Wang |
0 | 0 |
Shunbing Yu |
0 | 0 |
Tianmin Zhu |
0 | 0 |
Wei Zhang |
0 | 0 |
Jianhua Wu |
0 | 0 |
Yunpei Guo |
0 | 0 |
Chao Lu |
0 | 0 |
Cheng Zhang |
0 | 0 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
